Safety in oHCM Therapy: How and When to Transition Treatment?
Anjali Owens, MD
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Florian Rader, MD
Molecular Precision: How Myosin Inhibitors Redefine Control
Ahmad Masri, MD, MS
Modern Obstructive HCM Care: From Unmet Needs to Individualized Myosin Inhibitor Therapy
Michael Nassif, MD, MSc
From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
Advancing Care for Women With Aortic Stenosis*: 2-Year Outcomes for Women in the 5-Year SMART Trial
Roxana Mehran, MD, FSCAI
The Overlooked Valve: Why Women With Aortic Stenosis Fall Through the Cracks
Pam R. Taub, MD, FACC, FASPC
Quantifying CKD-aP: Tools for Better Care
James Burton, DM, FRCP
Emilio Sanchez, MD, PhD
CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Decoding Itch in CKD: From CKD-aP Suspicion to Solution
Lucio Manenti, MD, PhD
CKD-aP: Beyond the Surface
Is CKD-aP Hiding in Your Dialysis Center?